With the release of a new ICD-10-CM code for the novel coronavirus (COVID-19), hospitals now have a method to capture and report this critical disease. Although the code itself is relatively straightforward and likely won’t stir up confusion the way coding for complex diagnoses (such as sepsis) does, correctly documenting and coding COVID-19 is crucial to turning the tide on the national public health emergency.
CMS released an update to its FAQ on coding and billing for the novel coronavirus (COVID-19) on March 23. The FAQ clarifies the use of HCPCS and CPT® codes for diagnostic laboratory services.
CMS announced blanket waivers of certain Medicare requirements to prevent gaps in care for beneficiaries affected by the novel coronavirus (COVID-19) public health emergency. The agency released billing instructions and a set of Q&As.
CMS provided updated coding and billing information in its Clinical Laboratory Fee Schedule (CLFS) for organizations performing tests for COVID-19 and providing treatment for confirmed or suspected COVID-19 infections.
National Correct Coding Initiative (NCCI) edits can be a major stumbling block in the billing process. Take a look at the different types of NCCI edits and strategies to address them.
Like other services covered by Medicare, observation must be reasonable and necessary or, in other words, medically necessary. The physician must document that they assessed patient risk to determine that the patient would benefit from observation services.
